BioSpace News Archive

HBM Healthcare Investments, Vivo Capital, BlackRock, Omega Funds, Pivotal BioVentures, and Goldman Sachs join existing investors Frazier Healthcare Partners, Bain Capital Life Sciences, OrbiMed and RA Capital Management

CRISPR prime editing would theoretically allow that precise editing without the limitations of base editing.

Here are 10 ideas for using cover letters in ways you may not have thought of.

Great Bay Bio is pleased to announce that a strategic cooperation was reached with Guangzhou Boji Medical Biotechnological Co., Ltd. to jointly develop GBB101, a new long-acting injectable biologics for the treatment of anemia caused by Chronic Kidney Disease A new joint venture company has been created to share the R&D achievements of the project, including intellectual property rights and any rights and interests arising in the R&D process.

Despite booming commercial interest in plant-based and cultivated meat, funding for academic research lags behind and the industries face a dearth of the open-access data that will be required to overcome technical hurdles and scale-up to price parity

Porton Biopharma Ltd has announced that it has signed a modification to its contract with the US National Institute of Health’s National Institute of Allergy and Infectious Diseases to advance a next generation intra-nasal anthrax vaccine into the clinical-trial phase.

New research from the Karolinska Institute has demonstrated the I-DOT’s capability to facilitate genetic research in cancer diagnostics. The Karolinska Institute in Sweden is at the forefront of cancer research in the world.

Here are some of the top biotech influences of this generation.

Centrient Pharmaceuticals (“Centrient”), the global leader in the production and commercialisation of sustainable, enzymatic antibiotics, next generation statins and anti-fungals, announced that it has

MorphoSys AG will publish its first nine months’ 2019 results on October 29, 2019 at 10:00pm CET